AngioDynamics
ANGO
14.19
-0.23
-1.60%
AngioDynamics
US · ANGO
#3631 by market cap
14.19
-0.23
-1.60%
Live - 5344 symbols - heartbeat 211s ago
· 2026-10-08 09:19
Pre-market
13.74
-3.20%
After-hours
14.61
+2.96%
Overnight
14.50
+2.18%
- Market cap
- 596.75M
- P/E (TTM)i
- -16.13
- P/Bi
- 3.49
- EPSi
- -0.88
- Div yieldi
- 0.00%
- 52W posi
- 70%
Reader sentiment
Are you bullish or bearish on ANGO?
Anonymous reader poll. Unscientific, not investment advice.
Recent news
-
Rating change
H.C. Wainwright Maintains AngioDynamics(ANGO.US) With Buy Rating, Maintains Target Price $14Market Newswire · 2024/12/10
-
Rating change
AngioDynamics (ANGO) Gets a Buy From H.C. WainwrightTipRanks · 2024/10/4
-
Rating change
Lake Street Initiates AngioDynamics(ANGO.US) With Buy Rating, Announces Target Price $24Market Newswire · 2026/1/7
-
Rating change
Oppenheimer Maintains AngioDynamics(ANGO.US) With Buy Rating, Raises Target Price to $16Market Newswire · 2025/1/10
-
Rating change
H.C. Wainwright Maintains AngioDynamics(ANGO.US) With Buy Rating, Raises Target Price to $16Market Newswire · 2025/4/8
-
Rating change
H.C. Wainwright Maintains AngioDynamics(ANGO.US) With Buy Rating, Raises Target Price to $15Market Newswire · 2025/1/10
-
Rating change
CCORF Maintains AngioDynamics(ANGO.US) With Buy Rating, Maintains Target Price $18Market Newswire · 2026/1/7
-
H.C. Wainwright Maintains AngioDynamics(ANGO.US) With Buy Rating, Maintains Target Price $19Market Newswire · 2026/7/16
-
Rating change
CCORF Maintains AngioDynamics(ANGO.US) With Buy Rating, Raises Target Price to $18Market Newswire · 2025/10/3
-
H.C. Wainwright Maintains AngioDynamics(ANGO.US) With Buy Rating, Raises Target Price to $19Market Newswire · 2026/7/16
-
Rating change
CCORF Maintains AngioDynamics(ANGO.US) With Buy Rating, Cuts Target Price to $12Market Newswire · 2024/10/4
-
Rating change
CCORF Initiates AngioDynamics(ANGO.US) With Buy Rating, Announces Target Price $15Market Newswire · 2025/1/10
-
Rating change
Oppenheimer Maintains AngioDynamics(ANGO.US) With Buy Rating, Maintains Target Price $13Market Newswire · 2024/10/5
-
Freedom Capital Markets Initiates AngioDynamics(ANGO.US) With Buy Rating, Announces Target Price $16Market Newswire · 2026/4/6
-
Rating change
Analysts Are Bullish on These Healthcare Stocks: Biohaven Ltd. (BHVN), AngioDynamics (ANGO)TipRanks · 2026/5/29
-
Lake Street Maintains AngioDynamics(ANGO.US) With Buy Rating, Maintains Target Price $24Market Newswire · 2026/7/14
-
Rating change
CCORF Maintains AngioDynamics(ANGO.US) With Buy Rating, Maintains Target Price $17Market Newswire · 2025/8/13
-
Rating change
CCORF Maintains AngioDynamics(ANGO.US) With Buy Rating, Maintains Target Price $12Market Newswire · 2024/12/10
-
H.C. Wainwright Maintains AngioDynamics(ANGO.US) With Buy Rating, Maintains Target Price $16Market Newswire · 2026/4/6
Headlines are aggregated automatically and are not independently verified or edited by our team.
Quote time 2026-10-08 09:19:27 · For reference only, not investment advice and not tailored to your situation.